2009
DOI: 10.1007/s10585-009-9288-1
|View full text |Cite
|
Sign up to set email alerts
|

Anti-metastatic effects of liposomal gemcitabine in a human orthotopic LNCaP prostate cancer xenograft model

Abstract: Fatal outcomes of prostate carcinoma (PCa) mostly result from metastatic spread rather than from primary tumor burden. Here, we monitored growth and metastatic spread of an orthotopic luciferase/GFP-expressing LNCaP PCa xenograft model in SCID mice by in vivo imaging and in vitro luciferase assay of tissues homogenates. Although the metastatic spread generally shows a significant correlation to primary tumor volumes, the susceptibility of various tissues to metastatic invasion was different in the number of af… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

4
19
0

Year Published

2009
2009
2021
2021

Publication Types

Select...
7
2

Relationship

2
7

Authors

Journals

citations
Cited by 30 publications
(26 citation statements)
references
References 49 publications
(71 reference statements)
4
19
0
Order By: Relevance
“…Recently, a strong antimetastatic effect of empty liposomes consisting only of hydrogenated PC and cholesterol was reported in two different orthotopic pancreatic tumor models in mice (AsPC1, LNCaP) while the growth of the primary tumors was not affected [35,36]. Investigating the underlying mode of action revealed that the PC degradation product, namely hydrogenated lysoPC, is most likely pivotal for the observed effect.…”
Section: Introductionmentioning
confidence: 99%
“…Recently, a strong antimetastatic effect of empty liposomes consisting only of hydrogenated PC and cholesterol was reported in two different orthotopic pancreatic tumor models in mice (AsPC1, LNCaP) while the growth of the primary tumors was not affected [35,36]. Investigating the underlying mode of action revealed that the PC degradation product, namely hydrogenated lysoPC, is most likely pivotal for the observed effect.…”
Section: Introductionmentioning
confidence: 99%
“…The results in terms of cytotoxic activity were very promising in different in vitro and in vivo studies [13][14][15][16][17]. In our previous work, in order to obtain both a physical and a chemical protection of the drug, we have synthesized and incorporated into liposomes lipophilic GEM prodrugs that were obtained by linking the N 4 -amino group with linear acyl chains of different length which enhanced drug incorporation and antitumoral activity [18,19].…”
Section: Introductionmentioning
confidence: 99%
“…However, the limitation of gemcitabine is its rapid inactivation by the deoxycytidine deaminase following intravenous administration, which leads to the use of innovative drug delivery systems, such as liposomes, for improving its pharmacological and biopharmaceutical properties. To overcome these limitations of gemcitabine, various types of delivery systems, including liposomes, had been studied for anticancer effects in prostate cancer 26 , lung cancer 27 and pancreatic cancer 28 .…”
Section: Introductionmentioning
confidence: 99%